Previous 10 | Next 10 |
home / stock / cgnsf / cgnsf news
Partnership will accelerate adoption of Cognetivity's AI platform in Japan and other Asia-Pacific territories Vancouver, British Columbia--(Newsfile Corp. - June 13, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , is t...
US Medicare & Medicaid to require data collection as part of drug reimbursement Vancouver, British Columbia--(Newsfile Corp. - June 6, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE:1UB) ("the Company" or "Cognetivity") , a technology company that has cr...
Agreement aims at further development of Cognetivity's AI (Artificial Intelligence) platform through investigating comorbidities in diabetes and dementia Vancouver, British Columbia--(Newsfile Corp. - May 31, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (...
The news highlights the urgent need for more consistent, wide scale detection of the disease at an early stage Vancouver, British Columbia--(Newsfile Corp. - May 9, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") i...
Company to provide its AI-powered cognitive assessment technology to policyholders in Japanese market to promote proactive approach to brain health Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ...
Appointment brings deep industry and investment experience to the company, helping the company's expansion and growth globally Vancouver, British Columbia--(Newsfile Corp. - April 20, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Co...
Company presents key data on measuring impact of sleep disorders on brain health; University of Oxford extends collaboration on monitoring changes in cognition of older adults Vancouver, British Columbia--(Newsfile Corp. - March 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQ...
Expansion of first-phase deployment follows excellent published results, showing cross-cultural validity, leading to further expansion and market traction in Asia Vancouver, British Columbia--(Newsfile Corp. - March 8, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) ...
Latest Agreement Signals Continued, Rapid Commercial Growth in Middle East Region Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity") , a technology company that ...
Peer-reviewed article demonstrates effectiveness of company's technology in major disease area with global application for the detection and monitoring of disease Vancouver, British Columbia--(Newsfile Corp. - February 22, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (FSE: 1UB) (OTCQB: CGNS...
News, Short Squeeze, Breakout and More Instantly...
Cognetivity Neurosciences Ltd Company Name:
CGNSF Stock Symbol:
OTCMKTS Market:
Atlas Lithium Corporation (ATLX) is expected to report $-0.47 for Q4 2023 Capital Product Partners L.P. (CPLP) is expected to report $0.7 for Q4 2023 WisdomTree Inc. (WT) is expected to report $0.11 for Q4 2023 Mitsubishi Corporation (MSBHF) is expected to report for Q3 2024 C3is ...
POSCO Holdings Inc. American Depositary Shares (Each representing 1/4th of a share of) (PKX) is expected to report for Q4 2023 Middlefield Banc Corp. (MBCN) is expected to report $0.53 for Q4 2023 American Business Bank (AMBZ) is expected to report for Q4 2023 Regencell Bioscience Hol...
Comerica Incorporated (CMA) is expected to report $1.38 for Q4 2023 ICICI Bank Limited (IBN) is expected to report $0.32 for Q3 2024 Engie Brasil Energia S.A. ADR (EGIEY) is expected to report for Q4 2023 Auto Parts 4Less Group (FLES) is expected to report for quarter end 2023-10-31 ...